AI Chat: ChatGPT, AI News, Artificial Intelligence, OpenAI, Machine Learning OpenAI Invests in Sam Altman’s New Brain Interface Startup Merge Labs
Jan 15, 2026
Explore the groundbreaking intersection of brain-computer interface technology and AI. Discover OpenAI's investment in Merge Labs, which aims for noninvasive methods using ultrasound, contrasting with Neuralink's surgical approaches. Delve into visionary goals, blending human biology with AI for enhanced intelligence. The discussion also highlights potential conflicts from circular investing in the BCI landscape. Is this the future of human-AI interaction, or just hype? Tune in for a thought-provoking analysis!
AI Snips
Chapters
Transcript
Episode notes
From Fear To Familiarity With Neuralink
- Early fear around Neuralink gave way to acceptance because it showed clear benefits for people with paralysis.
- Jaden Schaefer describes demos where users regain communication and control, making the tech feel familiar.
Non‑Surgical Neural Interfaces Are The Pitch
- Merge Labs aims to connect human brains directly to AI using non‑surgical methods like ultrasound and molecular signals.
- Jaden Schaefer warns this approach shifts interaction from screens to direct neural interfaces, which feels dystopian to some.
Big Seed, Big Credibility
- Merge Labs positions itself as a research lab focused on connecting brains to AI and just exited stealth with a large seed round.
- OpenAI reportedly invested in the round, valuing Merge Labs near $850M and accelerating its credibility.